medRxiv · Jul 31, 2026

Accelerometer-derived Step Metrics and Quality of Life in Individuals with and without Cardiovascular Diseases

By Schootemeijer S, Kroesen SH, Stens NA et al.

Background and AimsSteps are increasingly used to prescribe physical activity, but their impact on quality of life (QoL) remains unclear. We examined the dose-response association between step metrics and QoL, and whether cardiovascular disease (CVD) status moderates this association. MethodsIndividual-level data of five studies were pooled. Physical activity was measured with thigh-worn accelerometry. We assessed steps/day, daily minutes of fast stepping ([≥]100 steps/min), peak 1- and 30- min cadence. We investigated the association of step metrics and QoL (questionnaire-based; standardized) with multivariable (non-)linear regression, and the interaction with CVD status. ResultsWe included 9,371 participants (62 [54-68] years; 47% female), comprising 1,977 individuals with and 7,394 without CVD. Significant, curvilinear dose-response associations between step metrics and QoL were found. The optimal step volume was 6,561 steps/day which associated with a 0.35 SD (95%CI: 0.28-0.42) higher QoL compared to the referent 4,000 steps/day. The optimal doses for peak 1-min and peak 30-min cadence were 107 steps/minute (+0.34 SD; 95%CI: 0.28-0.41) and 74 steps/minute (+0.29 SD; 95%CI: 0.24-0.34) respectively, compared to references of 90 and 60 steps/minute. Only fast stepping interacted with CVD status, with a lower optimum in those with versus without CVD (4 minutes/day, +0.20 SD, 95%CI: 0.12-0.28 versus 9 minutes/day, +0.19 SD, 95%CI: 0.12-0.25), compared to the referent 2 minutes/day. ConclusionsStep metrics were curvilinearly associated with QoL with optimal benefits at [~]6,500 steps/day. Optimal QoL benefits can be reached at feasible stepping targets, and at slightly fewer daily minutes of fast stepping in CVD versus non-CVD. Structured graphical abstractO_ST_ABSKey QuestionsC_ST_ABSO_LIIs there a dose-response association between step metrics and health-related quality of life (QoL)? C_LIO_LIDoes the cardiovascular disease (CVD) health status moderate this association? C_LI Key FindingsO_LIMore steps/day and time spent at fast stepping are associated with better QoL following a curvilinear dose-response curve. C_LIO_LIThe optimal step volume is 6,561 steps/day, which was independent of CVD status. C_LIO_LIIndividuals with CVD may gain optimal QoL levels at slightly less time of fast stepping (4 min/day) than those without CVD (9 min/day). C_LI Take Home MessageMore steps and steps at a higher intensity are associated with better QoL. Optimal QoL benefits could be gained at feasible stepping targets (i.e. 4 min/day of fast stepping for CVD, 9 min/day for those without CVD). O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=125 SRC="FIGDIR/small/26359231v1_ufig1.gif" ALT="Figure 1"> View larger version (43K): org.highwire.dtl.DTLVardef@1f5ccb3org.highwire.dtl.DTLVardef@521357org.highwire.dtl.DTLVardef@73e835org.highwire.dtl.DTLVardef@19214bc_HPS_FORMAT_FIGEXP M_FIG C_FIG

doi.org/10.64898/2026.07.30.26359231Open accessPopulations

AgingResearch.News